Fengjin Zhou

Fengjin Zhou


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2023 in Bioactive Materials
Verified
Journal Article
Open access
YWYili Wang
Yili Wang
QLQiushui Lin
Qiushui Lin
HZHao Zhang
Hao Zhang
SWSicheng Wang
Sicheng Wang
JCJin Cui
Jin Cui
JSJiacan Su
Jiacan Su
Diabetes mellitus is a chronically inflamed disease that predisposes to delayed fracture healing. Macrophages play a key role in the process of fracture healing by undergoing polarization into either M1 or M2 subtypes, which respectively exhibit pro-inflammatory or anti-inflammatory functions. Therefore, modulation of macrophage polarization to the M2 subtype is beneficial for fracture healing. Exosomes perform an important role in improving the osteoimmune microenvironment due to their extremely low immunogenicity and high bioactivity. In this study, we extracted the M2-exosomes and used them to intervene the bone repair in diabetic fractures. The results showed that M2-exosomes significantly modulate the osteoimmune microenvironment by decreasing the proportion of M1 macrophages, thereby accelerating diabetic fracture healing. We further confirmed that M2-exosomes induced the conversion of M1 macrophages into M2 macrophages by stimulating the PI3K/AKT pathway. Our study offers a fresh perspective and a potential therapeutic approach for M2-exosomes to improve diabetic fracture healing.

3 October 2022 in Frontiers in Nutrition
Verified
Journal Article
Open access
ACAiyong Cui
Aiyong Cui
PXPeilun Xiao
Peilun Xiao
YMYuzhuo Ma
Yuzhuo Ma
ZFZhiqiang Fan
Zhiqiang Fan
FZFengjin Zhou
Fengjin Zhou
LZLiang Zhang
Liang Zhang
Background: The National Health and Nutrition Examination Surveys (NHANES) collect and release data to the public every 2 years. The latest NHANES study on the vitamin D status of Americans was based on data from 2001 to 2014, and the latest data (2015–2016 and 2017–2018) have not been studied yet. Thus, we extracted all the available data from NHANES (2001–2018), aiming to analyze the prevalence and trends of vitamin D deficiency (VDD) in the US population to bridge the research gap.Methods: According to previous studies and nutritional guidelines for vitamin D, severe VDD was defined as serum 25(OH)D levels of 75 nmol/L. We comprehensively estimated the prevalence of serum 25(OH)D levels of 75 nmol/L in Americans and described trends in vitamin D status from 2001 to 2018. Weighted multivariate linear regression models were used to explore the predictors of VDD. All analyses and the data were adjusted for the complex sampling design of NHANES using Mobile Examination Center (MEC) weights.Results: Based on the most recent data of 71,685 participants, our study showed that the weighted prevalence of severe and moderate VDD was 2.6% and 22.0%, and the prevalence of vitamin D insufficiency (VDI) and sufficiency was 40.9% and 34.5%. The prevalence of severe and moderate VDD was higher in women, non-Hispanic black Americans, people aged 20–29 years, and during the season of winter. From 2001 to 2018, we found a slight linear decrease in the prevalence of moderate VDD (coefficient = −0.847; P = 0.009) and VDI (coefficient = −0.810; P = 0.014). We also found a slight linear increase in vitamin D sufficient (coefficient = 1.693; P = 0.004). However, no trend change was observed in severe VDD (coefficient = −0.037; P = 0.698). Age, sex, ethnicity, season, sun-protective behaviors, lower BMI, lower socioeconomic status (SES), drinking, and lower milk consumption were predictors of severe VDD.Conclusion: Vitamin D deficiency is still prevalent in the United States, especially in non-Hispanic black Americans, women, individuals aged 20–29, and during winter. Therefore, individuals, healthcare providers, and policymakers should take public health measures to develop and implement prevention strategies to deal with VDD.

1 July 2023 in Bioactive Materials
Verified
Journal Article
Open access
YHYan Hu
Yan Hu
HZHao Zhang
Hao Zhang
SWSicheng Wang
Sicheng Wang
LCLiehu Cao
Liehu Cao
FZFengjin Zhou
Fengjin Zhou
JSJiacan Su
Jiacan Su
The necessity of disease models for bone/cartilage related disorders is well-recognized, but the barrier between ex-vivo cell culture, animal models and the real human body has been pending for decades. The organoid-on-a-chip technique showed opportunity to revolutionize basic research and drug screening for diseases like osteoporosis and arthritis. The bone/cartilage organoid on-chip (BCoC) system is a novel platform of multi-tissue which faithfully emulate the essential elements, biologic functions and pathophysiological response under real circumstances. In this review, we propose the concept of BCoC platform, summarize the basic modules and current efforts to orchestrate them on a single microfluidic system. Current disease models, unsolved problems and future challenging are also discussed, the aim should be a deeper understanding of diseases, and ultimate realization of generic ex-vivo tools for further therapeutic strategies of pathological conditions.

1 January 2025 in Theranostics
Verified
Journal Article
Open access
PDF file
CSCongyi Shen
Congyi Shen
ZZZiyang Zhou
Ziyang Zhou
RLRuiyang Li
Ruiyang Li
SYShike Yang
Shike Yang
DZDongyang Zhou
Dongyang Zhou
JSJiacan Su
Jiacan Su
Osteoarthritis (OA) is a common joint disease characterized by cartilage degeneration. It can cause severe pain, deformity and even amputation risk. However, existing clinical treatment methods for cartilage repair present certain deficiencies. Meanwhile, the repair effect of cartilage tissue engineering is also unsatisfactory. Cartilage organoids are multicellular aggregates with cartilage-like three-dimensional structure and function. On the one hand, cartilage organoids can be used to explore the pathogenesis of OA by constructing disease models. On the other hand, it can be used as filler for rapid cartilage repair. Extracellular matrix (ECM)-like three-dimensional environment is the key to construct cartilage organoids. Silk fibroin (SF)-based hydrogels not only have ECM-like structure, but also have unique mechanical properties and remarkable biocompatibility. Therefore, SF-based hydrogels are considered as ideal biomaterials for constructing cartilage organoids. In this review, we reviewed the studies of cartilage organoids and SF-based hydrogels. The advantages of SF-based hydrogels in constructing cartilage organoids and the iterative optimization of cartilage organoids through designing hydrogels by using artificial intelligence (AI) calculation are also discussed. This review aims to provide a theoretical basis for the treatment of OA using SF-based biomaterials and cartilage organoids.

25 May 2023 in Materials Horizons
Verified
Journal Article
Closed access
PDF file
SWShunli Wu
Shunli Wu
HZHao Zhang
Hao Zhang
SWSicheng Wang
Sicheng Wang
JSJinru Sun
Jinru Sun
YHYan Hu
Yan Hu
JSJiacan Su
Jiacan Su
A novel strategy to prepare an in situ nanocomposite FLPKT hydrogel is proposed, in which ultrasound-triggered in situ gelation using ROS is a regulatory mechanism. Moreover, ROS generation and KGN release effectively improved cartilage regeneration.

1 January 2025 in Theranostics
Verified
Journal Article
Open access
PDF file
JWJian Wang
Jian Wang
XCXiao Chen
Xiao Chen
RLRuiyang Li
Ruiyang Li
SWSicheng Wang
Sicheng Wang
ZGZhen Geng
Zhen Geng
JSJiacan Su
Jiacan Su
Organoids, self-organized structures derived from stem cells cultured in a specific three-dimensional (3D) in vitro microenvironment, have emerged as innovative platforms that closely mimic in vivo cellular behavior, tissue architecture, and organ function. Bone organoids, a frontier in organoid research, can replicate the complex structures and functional characteristics of bone tissue. Recent advancements have led to the successful development of bone organoids, including models of callus, woven bone, cartilage, trabecular bone, and bone marrow. These organoids are widely utilized in establishing bone-related disease models, bone injury repair, and drug screening. However, significant discrepancies remain between current bone organoids and human skeletal tissues in terms of morphology and functionality, limiting their ability to accurately model human bone physiology and pathology. To address these challenges and promote standardization in the construction, evaluation, and application of bone organoids, we have convened experts and research teams with substantial expertise in the field. By integrating existing research findings, this consortium aims to establish a consensus to guide future research and application of bone organoids.